[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350290-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-350290-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","ccl3-is-produced-by-aged-neutrophils-across-cancers-and-promotes-tumor-growth","CCL3 is produced by aged neutrophils across cancers and promotes tumor growth","","Tumor-associated neutrophils (TANs) are widespread across cancers, but their phenotypic diversity and functional states have been insufficiently characterized. The study introduces a cell-type probability classifier to recover low-transcript neutrophils from scRNA-seq datasets, enabling pan-cancer analysis of TAN heterogeneity. Across more than 190 human and murine tumors, the work identifies a conserved differentiation trajectory ending in a terminal CCL3hi state with protumor programs. CCL3hi TANs increase in hypoxic tumor niches and neutrophil-derived CCL3 sustains TAN survival via CCR1-dependent signaling, establishing CCL3 as a marker and functional driver of pro-tumor neutrophils.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ccl3-is-produced-by-aged-neutrophils-across-cancers-and-promotes-tumor-growth/350290/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ccl3-is-produced-by-aged-neutrophils-across-cancers-and-promotes-tumor-growth/350290.png","ImageObject",300,407,{"name":42,"@type":43},"Chumphorn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about tumor-associated neutrophils?","Question",{"text":63,"@type":64},"TANs are abundant across cancers, but their phenotypic diversity and functional states are not well defined. The study focuses on identifying and characterizing these states reliably from scRNA-seq data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study improve analysis of neutrophils in scRNA-seq datasets?",{"text":68,"@type":64},"It introduces a cell-type probability classifier that recovers low-transcript neutrophils commonly lost in scRNA-seq analyses, enabling unified pan-cancer characterization of TAN heterogeneity.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the significance of the terminal CCL3hi TAN state?",{"text":72,"@type":64},"A conserved differentiation trajectory across many human and murine tumors culminates in a terminal CCL3hi state. This state shows protumor transcriptional programs, including features related to hypoxic adaptation and senescence.",{"name":74,"@type":61,"acceptedAnswer":75},"How does neutrophil-derived CCL3 promote tumor progression?",{"text":76,"@type":64},"Mechanistic perturbations in mice show that CCL3 sustains TAN survival in hypoxic tumor regions through CCR1-dependent signaling, thereby promoting tumor progression.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},350290,1790800630,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":101,"preview_urls":150},2336475401981,"https://ap-avatar.wpscdn.com/avatar/22000c94efd8d5204d?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786935347598174694","Author Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \n\n| | HHS Public Access\u003Cbr>Author manuscript\u003Cbr>Cancer Cell. Author manuscript; available in PMC 2026 May 16. |\n| --- | --- |\n\nPublished in final edited form as:  \nCancer Cell. 2026 March 09; 44(3): 624–640.e12. doi:10.1016/j.ccell.2026.01.006 .  \nCCL3 is produced by aged neutrophils across cancers and promotes tumor growth  \nEvangelia Bolli 1,2,3,24 , Pratyaksha Wirapati 1,2,3,24 , Mehdi Hicham 1,2,3 , Yuxuan Xie 1,2,3 , Marie Siwicki4 , Florent Duval 1,2,3 , Anne-Gaëlle Goubet 1,2,3 , Máté Kiss 1,2,3 , Béatrice Zitti 1,2,3 ,  \nThomas Zwahlen 1,2,3,5,6 , Sheri Mcdowell 1,2,3 , Ruben Bill 1,2,7 , Simona Angerani 1 , Camilla Engblom8 , Seth Anderson9,10 , Aiping Jiang9,10 , Oliver Hartley 1 , David B. Sykes 11 , Maja Jankovic 12 , Nadine Fournier5,6 , Matthias Gunzer13,14 , David Tarussio 15 , Stéphanie Tissot 15 , Peter M. Sadow 10,16 , William C. Faquin 10,16 , Moshe Sade-Feldman9,10,17 , Ralph Weissleder11,18,19,20 , Sara Pai21 , François Mercier12 , Robert Manguso9,10,17 , Mikaël J. Pittet 1,2,3,22,23,25,26,*  \n1 Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland  \n2AGORA Cancer Research Center, and Swiss Cancer Center Leman, Lausanne, Switzerland  \n3Translational Research Center in Oncohaematology, University of Geneva, Geneva, Switzerland  \n4Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada  \n5Translational Data Science Group, Swiss Institute of Bioinformatics, Lausanne, Switzerland  \n6Bioinformatics Core Facility, Swiss Institute of Bioinformatics, Lausanne, Switzerland  \n7 Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland  \n8SciLifeLab, Department of Medicine, Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden  \n9Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA  \n10Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA  \n11Mass General Brigham Cancer Center, Boston, MA, USA  \n12Lady Davis Institute for Medical Research, McGill University, Montréal, Quebec, Canada  \n13 Institute for Experimental Immunology and Imaging, University Hospital Essen, University of Duisburg-Essen, Essen, Germany  \n14Leibniz-Institut für Analytische Wissenschaften ISAS-e.V. , Dortmund, Germany  \nThis is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \n*[Correspondence: mikael.pittet@unige.ch](Correspondence: mikael.pittet@unige.ch).  \nAUTHOR CONTRIBUTIONS  \nE.B., P.W., and M.J.P. developed the concept, prepared figures, and wrote the article. E.B. designed, performed, and analyzed mouse and human experiments. P.W. developed the cell type classifier and performed bioinformatics. M.J.P. supervised experiments and analyses. Experimental support: R.B., F.D., C.E., W.C.F., M.S.F., A.G.G., M.G., M.L.H., M.K., S.M., S.P., M.S., P.M.S., D.B.S., D.T., S.T., and B.Z. Materials and analysis support: S.A., N.F., O.H., A.J., M.J., F.M., R.M., R.W., Y.X., and T.Z.  \nAuthor Manuscr ipt Author Manuscr ipt Author Manuscr ipt Author Manuscript  \nBolli et al. Page 2  \n15 Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland  \n16 Department of Surgery, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA  \n17 Department of Medicine, Massachusetts General Hospital, Boston, MA, USA  \n18Center for Systems Biology, Massachusetts General Hospital, Cambridge St, Boston, MA, USA  \n19 Department of Radiology, Massachusetts General Hospital, Fruit St, Boston, MA, USA  \n20 Department of Systems Biology, Harvard Medical School, Longwood Ave, Boston, MA, USA  \n21 Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, USA  \n22Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerl","cbCaigDgwhsoBUJ7","https://ap.wps.com/l/cbCaigDgwhsoBUJ7","pdf",4587866,49,"English","# Summary\n# Introduction\n# Key Findings\n## Classifier recovers low-transcript TANs\n## CCL3hi terminal state and protumor programs\n## Enrichment in hypoxic tumor niches\n## Mechanistic role of neutrophil-derived CCL3 via CCR1","[{\"question\":\"What problem does the study address about tumor-associated neutrophils?\",\"answer\":\"TANs are abundant across cancers, but their phenotypic diversity and functional states are not well defined. The study focuses on identifying and characterizing these states reliably from scRNA-seq data.\"},{\"question\":\"How does the study improve analysis of neutrophils in scRNA-seq datasets?\",\"answer\":\"It introduces a cell-type probability classifier that recovers low-transcript neutrophils commonly lost in scRNA-seq analyses, enabling unified pan-cancer characterization of TAN heterogeneity.\"},{\"question\":\"What is the significance of the terminal CCL3hi TAN state?\",\"answer\":\"A conserved differentiation trajectory across many human and murine tumors culminates in a terminal CCL3hi state. This state shows protumor transcriptional programs, including features related to hypoxic adaptation and senescence.\"},{\"question\":\"How does neutrophil-derived CCL3 promote tumor progression?\",\"answer\":\"Mechanistic perturbations in mice show that CCL3 sustains TAN survival in hypoxic tumor regions through CCR1-dependent signaling, thereby promoting tumor progression.\"}]","CCL3 is produced by aged neutrophils across cancers and promotes tumor growth | PDF",1790088262,123,[151,155,159,163,167],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c757cf830e97dfc7874ef2acc5bcb2f.webp",983,1272,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3dfae135bef723ff9ffa3e868460d3bb.webp",982,1270,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3824c012f31be7ae737593663506022a.webp",981,1269,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb99711ccf588ae23a4c03b12abe9adb.webp",980,1268,{"page_no":101,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/06e7493ba0f76f2ee74fe17ef32a9bec.webp",979,1267]